Sanofi
SNY
$42.78
$0.100.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -91.24% | -356.99% | 276.56% | 60.17% | |
| Total Depreciation and Amortization | 51.79% | 24.48% | 9.03% | -52.37% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 171.52% | -82.90% | -256.83% | 90.71% | |
| Change in Net Operating Assets | 3.19% | -- | -- | -- | |
| Cash from Operations | 103.64% | 3.19% | 15.63% | 2,205.59% | |
| Capital Expenditure | -4.99% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -1.73% | -- | -- | -- | |
| Cash Acquisitions | -148.65% | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -86.31% | 400.87% | 1,429.75% | -102.22% | |
| Cash from Investing | -103.86% | -496.82% | 429.85% | -102.22% | |
| Total Debt Issued | -32.56% | -- | -- | -- | |
| Total Debt Repaid | 16.69% | -- | -- | -- | |
| Issuance of Common Stock | -37.93% | -- | -- | -- | |
| Repurchase of Common Stock | 74.79% | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -3.77% | -- | -- | -- | |
| Other Financing Activities | 190.52% | 214.50% | 165.61% | -177.89% | |
| Cash from Financing | 53.41% | 27.87% | -506.49% | -175.51% | |
| Foreign Exchange rate Adjustments | 145.72% | -48.51% | -191.53% | -287.75% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -89.08% | -73.23% | 425.02% | 13.20% | |